Tips and tricks in tremor treatment.
Level 5 - mechanism / opinion, no new human data
Narrative review of clinical treatment strategies without systematic review methodology
PubMed 39043978 · doi:10.1007/s00702-024-02806-x
What was done
This narrative review summarizes clinical approaches, pharmacological algorithms, and interventional strategies for managing tremor across various etiologies, including Parkinson's disease, essential tremor (ET/ET+), and medication-induced forms.
What was found
No numerical results or effect sizes were reported in the abstract. Levodopa and D2-targeting dopamine agonists remain standard for Parkinson's tremor, with anticholinergics and clozapine used as reserve agents. Propranolol and primidone manage essential tremor, while 1-octanol and select anticonvulsants serve as alternative options. Deep brain stimulation, focused ultrasound, physical therapy, and wearable sensor wristbands provide additional therapeutic and diagnostic modalities.
Why it matters
It provides a broad clinical overview integrating traditional pharmacotherapy, surgical interventions, and wearable devices for individualized tremor management.
Limits
No quantitative data, sample sizes, or formal systematic search methodologies are reported in the abstract. As a narrative review, it is prone to selection bias and provides no direct comparative trial data.
Cited by
- context Patients with essential tremor do not experience a loss of dopamine, and administering dopaminergic drugs to them worsens their tremors.